CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 25,000 shares at an average $55.58 ($1,389,459)
- 4 Open-market sale Chief Scientific Officer sold 15,000 shares at an average $57.68 ($865,153)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy CEO, President and Secretary bought 2,000 shares at $11.00 ($22,000)
- 4 Other disposition Director disposed of 160,000 shares (other)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 3,750 shares at $48.15 ($180,563)
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Scientific Officer sold 15,000 shares at an average $48.39 ($725,814)
- 4 Open-market sale Chief Medical Officer sold 25,000 shares at an average $49.47 ($1,236,719)
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale Chief Medical Officer sold 25,000 shares at an average $51.45 ($1,286,157)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 25 of 34 · 672 filings